call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Infectious Disease In Vitro Diagnostics Market
Inquire Before Buying Request for Sample

Infectious Disease In Vitro Diagnostics Market

Home Healthcare And Pharmaceutical Infectious Disease In Vitro Diagnostics Market

Infectious Disease In Vitro Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product (Instruments, Reagents, Software); By Technology (Immunoassay, Molecular Diagnostics, Microbiology); By Application (MRSA, Streptococcus, Clostridium Difficile, VRE, CRE); By Test Location (Point of Care, Central Laboratories); By Region (North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA))

  • Published Date: April 2023
  • Report ID: BWC23324
  • Available Format: PDF
  • Page: 400

Report Overview

Rapidly aging population susceptible to infectious diseases and high demand for PoC testing owing to the pandemic are projected to propel the expansion of global infectious disease in vitro diagnostics market during the forecast period between 2023 and 2029.

Global Infectious Disease In Vitro Diagnostics Market- Industry Trends & Forecast Report, 2029

Global infectious disease in vitro diagnostics market size was estimated at USD 35.41 billion in 2022. During the forecast period between 2023 and 2029, the size of global infectious disease in vitro diagnostics market is anticipated to slightly decline at CAGR of -1.38% reaching a value of USD 32.98 billion by 2029. Major growth drivers for global infectious disease in vitro diagnostics market include increasing number of elderly individuals who are vulnerable to contagious illnesses, the COVID-19 pandemic's high requirement for point-of-care testing, greater recognition of the importance of early detection, and the growing occurrence of infectious diseases. The pandemic led to a significant shift in the market, as innovative products for testing SARS-CoV-2 were launched, resulting in substantial growth in the industry in 2020 and 2021. The increased adoption of these products played a crucial role in driving this growth. As a result of the rapid installation of PCR instruments, there has been an opportunity to utilize PCR tests for other infectious diseases, such as influenza, due to the declining need for SARS-CoV-2 tests in 2022. The growing geriatric population is expected to be one of the growth drivers of this market, given that aging is the leading risk factor for the development of diseases such as cardiovascular and neurological diseases.

Global Infectious Disease In Vitro Diagnostics Market – Overview

The infectious disease in vitro diagnostics (IVD) market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.

Global Infectious Disease In Vitro Diagnostics Market

Growth Drivers

High Demand for POC Testing Owing to the Pandemic

The global infectious disease in vitro diagnostics market is expected to receive a significant boost due to the high demand for point-of-care (POC) testing, driven by the ongoing pandemic. The need for immediate and accurate testing has led to a surge in demand for POC testing devices, which can provide quick results and aid in the effective management of infectious diseases. As a result, the market for infectious disease in vitro diagnostics is anticipated to experience substantial growth. The pandemic has highlighted the critical importance of efficient and accurate disease diagnosis and management, which is expected to further drive the growth of the infectious disease in vitro diagnostics market.

Growing Geriatric Population Susceptible to Infectious Diseases

The global infectious disease in vitro diagnostics market is expected to be propelled forward by the growing geriatric population, which is particularly susceptible to infectious diseases. With the world's aging population on the rise, the incidence of infectious diseases is also increasing. As a result, there is a growing need for accurate and efficient diagnostic tests to manage these diseases effectively. This is expected to boost the demand for infectious disease in vitro diagnostics devices, which aid in the detection and management of infectious diseases. With technological advancements and increased awareness about early detection and prevention, the infectious disease in vitro diagnostics market is likely to experience significant growth in the coming years, driven in large part by the aging population.

Restraints

High Cost Associated with Testing

The global infectious disease in vitro diagnostics market may face some hindrances due to the high costs associated with testing. While the need for accurate and efficient diagnostic tests is growing, the high cost of these tests can act as a barrier for individuals and healthcare systems. This may lead to a decrease in demand for infectious disease in vitro diagnostics devices, thereby restraining the market's growth. In addition, some low-income countries may not have the resources to invest in expensive diagnostic tests, further limiting the market's growth potential.

Impact of COVID -19 on Global Infectious Disease In Vitro Diagnostics Market

COVID 19 had a positive impact on the infectious disease in vitro diagnostics market. The increased need for detecting cases during the pandemic resulted in higher utilization rates of IVD devices. Regulatory authorities also made testing mandatory to contain the spread of the disease, further driving up demand for IVD devices. However, with the decrease in COVID-19 cases, there may be a decrease in demand for diagnostics. Nonetheless, the infectious disease in vitro diagnostics market is expected to continue growing due to the emergence of new diseases. More people are becoming health-conscious and monitoring their health regularly, which is also contributing to the rise in demand for IVD devices.

Global Infectious Disease In Vitro Diagnostics Market

Segmental Coverage

Global Infectious Disease In Vitro Diagnostics Market – By Product

By product, global infectious disease in vitro diagnostics market is divided into Instruments, Reagents, and Software. The reagents segment held the highest share in the infectious disease in vitro diagnostics market. This was primarily due to the high-volume usage of reagents for conducting tests, as well as the increasing need for COVID-19 testing programs to confirm both positive and negative results. The instruments segment also showed significant growth in 2020 and 2021, mainly due to the increase in PCR instrument installations for SARS-CoV-2 tests. Innovation is rapidly becoming a critical factor in achieving a competitive edge in the market.

Infectious Disease In Vitro Diagnostics Market

Global Infectious Disease In Vitro Diagnostics Market – By Technology

Based on technology, global infectious disease in vitro diagnostics market is divided into Immunoassay, Molecular Diagnostics, and Microbiology. The molecular diagnostics technology segment held the highest shar in the global industry and had the most significant market share. Molecular diagnostics are utilized for detecting major parasitic, bacterial, and viral infections. These tests are sophisticated and address the limitations of traditional testing methods, including inconsistent microorganism growth in manually prepared media, longer turnaround time, and low sensitivity. The immunoassay technology segment is predicted to experience consistent growth at a CAGR rate during the forecast period. As there is a growing need for quick PoC (Point-of-Care) tests, businesses are prioritizing the creation and distribution of immunoassays for COVID-19 detection.

Infectious Disease In Vitro Diagnostics Market Size

Global Infectious Disease In Vitro Diagnostics Market – By Application

Based on application, global infectious disease in vitro diagnostics market is segmented into MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, and Others (Respiratory Virus, Candida, TB And Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19). The COVID-19 application segment was the most dominant segment in the global industry. This can be attributed to the increased utilization of SARS-CoV-2 testing to curb the spread of the virus. Additionally, government initiatives to improve public testing and the launch of innovative products have been significant factors driving the growth of this sector. The TB and HIV segments have also experienced rapid growth due to improved testing methods. Furthermore, the respiratory virus segment's influenza testing has accelerated with the introduction of new diagnostic tests that allow differentiation between SARS-CoV-2 and influenza, facilitating prompt treatment. Tuberculosis, caused by Mycobacterium tuberculosis, is a contagious infection that remains a global epidemic. The WHO reported 130 new cases per 100,000 annually in 2020, but there has been a decline in the incidence rate in recent years, with a 9% drop between 2015 and 2019.

Global Infectious Disease In Vitro Diagnostics Market – By Test Location

Based on test location, global infectious disease in vitro diagnostics market is bifurcated into Point of Care and Central Laboratories segments. In 2022, the central laboratories test location segment held the dominant position in the global industry. Laboratory-based tests are considered more dependable as they offer higher accuracy in comparison to point-of-care tests. Moreover, laboratory tests can conduct complex tests that are not feasible in PoC or homecare settings. In addition, tests that allow patients to collect samples at home and send them to laboratories for testing make the testing process highly convenient. Although there is an increased demand for point-of-care tests to meet faster turnaround times, the COVID-19 pandemic has further boosted the growth of this segment, resulting in heightened demand for such products. The competitive advantage of this sector is due to its rapid turnaround time and low complexity.

Infectious Disease In Vitro Diagnostics Market Share

Global Infectious Disease In Vitro Diagnostics Market – By Region

The in-depth research report on the global infectious disease in vitro diagnostics market covers various country-specific markets across five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North America region holds the highest market share and is expected to experience further growth during the forecast period. The key drivers behind North America's success include a well-established diagnostic infrastructure, favorable government regulations, the presence of major companies, and the adoption of advanced technology. During the pandemic, North America was the region most severely impacted, resulting in an increase in the number of tests conducted and technological advancements. In contrast, the Asia-Pacific region is projected to grow at the fastest CAGR during the forecast period, as it has a high incidence of infectious diseases. Japan's growing geriatric population is a significant driver for IVD tests, while India is prone to many infectious diseases. As people become more aware of these diseases, there is a growing demand for tests and diagnostics. As tests are readily available at a low cost, these services are affordable to a large proportion of the population.

Competitive Landscape

Major players operating in global infectious disease in vitro diagnostics market include QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corp., and OraSure Technologies, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In April 2022 - The InspectIR COVID-19 Breathalyzer was approved by the FDA for rapid testing in mobile testing laboratories and doctors' offices, allowing for more accessible testing options.

  • In February 2022 - SRL Inc. introduced a new laboratory service called "IVD and COVID-19 testing," which accurately confirms negative COVID-19 tests. The instruments segment also showed significant growth in 2020 and 2021, mainly due to the increase in PCR instrument installations for SARS-CoV-2 tests.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period– 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)

Product/ Service Segmentation

Product, Technology, Application, Test Location, Region

Key Players

QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corp., OraSure Technologies, Inc.

 

 

By Product

  • Instruments

  • Reagents

  • Software

By Technology

  • Immunoassay

  • Molecular Diagnostics

  • Microbiology

By Application

  • MRSA

  • Streptococcus

  • Clostridium Difficile

  • VRE

  • CRE

By Test Location

  • Point of Care

  • Central Laboratories

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Infectious Disease In Vitro Diagnostics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing Geriatric Population Susceptible to Infectious Diseases
        2. High Demand for POC Testing Owing to the Pandemic
      2. Restraints
        1. High Cost Associated with Testing
      3. Opportunities
        1. Rising Prevalence of Infectious Diseases.
      4. Challenges
        1. Lack of Accurate result of Testing
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Infectious Disease In Vitro Diagnostics Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
        1. Instruments
        2. Reagents
        3. Software
      2. By Technology
        1. Immunoassay
        2. Molecular Diagnostics
        3. Microbiology
        4. Others
      3. By Application
        1. MRSA
        2. Streptococcus
        3. Clostridium Difficile
        4. VRE
        5. CRE
        6. Others (Respiratory Virus, Candida, TB And Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19)
      4. By Test Location
        1. Point of Care
        2. Central Laboratories
        3. Others
      5. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Infectious Disease In vitro Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
      5. By Country
        1. United States
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        2. Canada
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
  6. Europe Infectious Disease In vitro Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
      5. By Country
        1. Germany
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        2. United Kingdom
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        3. Italy
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        4. France
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        5. Spain
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        6. Belgium
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        7. Russia
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        8. The Netherlands
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        9. Rest of Europe
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
  7. Asia-Pacific Infectious Disease In vitro Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
      5. By Country
        1. China
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        2. India
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        3. Japan
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        4. South Korea
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        5. Australia & New Zealand
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        6. Indonesia
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        7. Malaysia
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        8. Singapore
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        9. Vietnam
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        10. Rest of APAC
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
  8. Latin America Infectious Disease In vitro Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
      5. By Country
        1. Brazil
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        2. Mexico
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        3. Argentina
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        4. Peru
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        5. Rest of LATAM
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
  9. Middle East & Africa Infectious Disease In vitro Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
      5. By Country
        1. Saudi Arabia
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        2. UAE
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        3. Qatar
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        4. Kuwait
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        5. South Africa
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        6. Nigeria
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        7. Algeria
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
        8. Rest of MEA
          1. By Product
          2. By Technology
          3. By Application
          4. By Test Location
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Infectious Disease In Vitro Diagnostics Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Infectious Disease In Vitro Diagnostics Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. QIAGEN
    2. BD
    3. bioMérieux SA
    4. F. Hoffmann-La Roche, Ltd.
    5. Hologic, Inc. (Gen-Probe)
    6. Abbott
    7. Quidel Corp.
    8. Siemens Healthineers AG
    9. Bio-Rad Laboratories, Inc.
    10. Danaher Corp.
    11. OraSure Technologies, Inc.
    12. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.    Qualitative Research
      1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

 

 

List of Figures

 

Figure 1       Global Infectious Disease In Vitro Diagnostics Segmentation      

Figure 2       Global Infectious Disease In Vitro Diagnostics Market Value Chain Analysis    

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 5       Global Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 6       Global Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 7       Global Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 8       Global Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 9       Global Infectious Disease In Vitro Diagnostics Market Share, By Region, By Value, 2019–2029 

Figure 10     North America Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 11     North America Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029     

Figure 12     North America Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 13     North America Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 14     North America Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 15     North America Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029     

Figure 16     United States Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 17     United States Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029     

Figure 18     United States Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 19     United States Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 20     United States Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 21     Canada Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 22     Canada Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 23     Canada Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 24     Canada Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 25     Canada Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 26     Europe Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 27     Europe Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 28     Europe Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 29     Europe Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 30     Europe Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 31     Europe Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 32     Germany Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 33     Germany Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 34     Germany Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 35     Germany Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 36     Germany Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029     

Figure 37     United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 38     United Kingdom Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029     

Figure 39     United Kingdom Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 40     United Kingdom Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 41     United Kingdom Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 42     Italy Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 43     Italy Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 44     Italy Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 45     Italy Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 46     Italy Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 47     France Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 48     France Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 49     France Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 50     France Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 51     France Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 52     Spain Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 53     Spain Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 54     Spain Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 55     Spain Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 56     Spain Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 57     Belgium Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 58     Belgium Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 59     Belgium Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 60     Belgium Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 61     Belgium Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029     

Figure 62     Russia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 63     Russia Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 64     Russia Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 65     Russia Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 66     Russia Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 67     The Netherlands Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029     

Figure 68     The Netherlands Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 69     The Netherlands Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 70     The Netherlands Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 71     Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 72     Rest of Europe Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029     

Figure 73     Rest of Europe Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 74     Rest of Europe Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 75     Rest of Europe Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 76     Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 77     Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 78     Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 79     Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029     

Figure 80     Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 81     Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 82     China Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 83     China Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 84     China Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 85     China Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 86     China Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 87     India Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 88     India Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 89     India Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 90     India Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 91     India Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 92     Japan Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 93     Japan Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 94     Japan Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 95     Japan Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 96     Japan Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 97     South Korea Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 98     South Korea Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 99     South Korea Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 100   South Korea Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029     

Figure 101   South Korea Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 102   Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 103   Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 104   Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 105   Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 106   Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029  

Figure 107   Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 108   Indonesia Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 109   Indonesia Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 110   Indonesia Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 111   Indonesia Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029     

Figure 112   Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 113   Malaysia Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 114   Malaysia Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 115   Malaysia Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 116   Malaysia Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029     

Figure 117   Singapore Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 118   Singapore Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 119   Singapore Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 120   Singapore Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029     

Figure 121   Singapore Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029     

Figure 122   Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 123   Vietnam Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 124   Vietnam Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 125   Vietnam Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 126   Vietnam Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029     

Figure 127   Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 128   Rest of APAC Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 129   Rest of APAC Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 130   Rest of APAC Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029     

Figure 131   Rest of APAC Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 132   Latin America Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 133   Latin America Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029     

Figure 134   Latin America Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 135   Latin America Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 136   Latin America Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 137   Latin America Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029     

Figure 138   Brazil Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 139   Brazil Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 140   Brazil Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 141   Brazil Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 142   Brazil Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 143   Mexico Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 144   Mexico Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 145   Mexico Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 146   Mexico Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 147   Mexico Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 148   Argentina Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 149   Argentina Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 150   Argentina Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 151   Argentina Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 152   Argentina Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029     

Figure 153   Peru Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 154   Peru Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 155   Peru Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 156   Peru Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 157   Peru Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 158   Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 159   Rest of LATAM Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029     

Figure 160   Rest of LATAM Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 161   Rest of LATAM Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 162   Rest of LATAM Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 163   Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 164   Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 165   Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 166   Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029      

Figure 167   Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 168   Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029 

Figure 169   Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 170   Saudi Arabia Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 171   Saudi Arabia Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 172   Saudi Arabia Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029     

Figure 173   Saudi Arabia Infectious Disease In Vitro Diagnostics Market Share, By Distriibution Application, By Value, 2019–2029      

Figure 174   UAE Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 175   UAE Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 176   UAE Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 177   UAE Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 178   UAE Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 179   Qatar Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Figure 180   Qatar Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029 

Figure 181   Qatar Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 182   Qatar Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 183   Qatar Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 184   Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 185   Kuwait Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 186   Kuwait Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 187   Kuwait Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 188   Kuwait Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 189   South Africa Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 190   South Africa Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 191   South Africa Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 192   South Africa Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029     

Figure 193   South Africa Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 194   Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 195   Nigeria Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 196   Nigeria Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 197   Nigeria Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 198   Nigeria Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 199   Algeria Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 200   Algeria Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 201   Algeria Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 202   Algeria Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 203   Algeria Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 204   Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Figure 205   Rest of MEA Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 206   Rest of MEA Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029     

Figure 207   Rest of MEA Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029     

Figure 208   Rest of MEA Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029          

 

List of Tables

 

Table 1        Global Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 2        Global Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 3        Global Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 4        Global Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 5        Global Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 6        Global Infectious Disease In Vitro Diagnostics Market Size, By Region, By Value, 2019–2029 

Table 7        North America Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 8        North America Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 9        North America Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 10      North America Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 11      North America Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 12      North America Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029

Table 13      United States Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 14      United States Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 15      United States Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 16      United States Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 17      United States Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 18      Canada Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 19      Canada Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 20      Canada Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 21      Canada Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 22      Canada Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 23      Europe Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 24      Europe Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 25      Europe Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 26      Europe Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 27      Europe Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 28      Europe Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029 

Table 29      Germany Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 30      Germany Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 31      Germany Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 32      Germany Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 33      Germany Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 34      United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 35      United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029     

Table 36      United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 37      United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029      

Table 38      United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 39      Italy Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 40      Italy Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 41      Italy Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 42      Italy Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029 

Table 43      Italy Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 44      France Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 45      France Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 46      France Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 47      France Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 48      France Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 49      Spain Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 50      Spain Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 51      Spain Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 52      Spain Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 53      Spain Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 54      Belgium Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 55      Belgium Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 56      Belgium Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 57      Belgium Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 58      Belgium Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 59      Russia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 60      Russia Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 61      Russia Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 62      Russia Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 63      Russia Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 64      The Netherlands Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029     

Table 65      The Netherlands Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 66      The Netherlands Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029      

Table 67      The Netherlands Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 68      Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 69      Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 70      Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 71      Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 72      Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 73      Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 74      Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 75      Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 76      Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 77      Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029     

Table 78      Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029

Table 79      China Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 80      China Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 81      China Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 82      China Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 83      China Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 84      India Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 85      India Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 86      India Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 87      India Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 88      India Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 89      Japan Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 90      Japan Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 91      Japan Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 92      Japan Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 93      Japan Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 94      South Korea Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 95      South Korea Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 96      South Korea Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 97      South Korea Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 98      South Korea Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029     

Table 99      Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 100    Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 101    Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 102    Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029      

Table 103    Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029  

Table 104    Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 105    Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 106    Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 107    Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 108    Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029     

Table 109    Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 110    Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 111    Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 112    Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 113    Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 114    Singapore Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 115    Singapore Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 116    Singapore Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 117    Singapore Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 118    Singapore Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029     

Table 119    Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 120    Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 121    Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 122    Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 123    Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 124    Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 125    Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 126    Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 127    Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 128    Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 129    Latin America Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 130    Latin America Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 131    Latin America Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 132    Latin America Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 133    Latin America Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 134    Latin America Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029

Table 135    Brazil Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 136    Brazil Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 137    Brazil Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 138    Brazil Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 139    Brazil Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 140    Mexico Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 141    Mexico Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 142    Mexico Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 143    Mexico Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 144    Mexico Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 145    Argentina Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 146    Argentina Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 147    Argentina Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 148    Argentina Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 149    Argentina Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029     

Table 150    Peru Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 151    Peru Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 152    Peru Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 153    Peru Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029 

Table 154    Peru Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 155    Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 156    Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 157    Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 158    Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 159    Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 160    Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 161    Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 162    Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 163    Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029      

Table 164    Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 165    Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029 

Table 166    Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 167    Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 168    Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 169    Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 170    Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Distriibution Application, By Value, 2019–2029      

Table 171    UAE Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 172    UAE Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 173    UAE Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029 

Table 174    UAE Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029 

Table 175    UAE Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 176    Qatar Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029 

Table 177    Qatar Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 178    Qatar Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 179    Qatar Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 180    Qatar Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 181    Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 182    Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 183    Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 184    Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 185    Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 186    South Africa Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 187    South Africa Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 188    South Africa Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 189    South Africa Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 190    South Africa Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029     

Table 191    Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 192    Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 193    Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 194    Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 195    Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 196    Algeria Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 197    Algeria Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029 

Table 198    Algeria Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 199    Algeria Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 200    Algeria Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 201    Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029       

Table 202    Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 203    Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029     

Table 204    Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029     

Table 205    Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029     

Table 206    QIAGEN Company Overview

Table 207    QIAGEN Financial Overview

Table 208    BD Company Overview

Table 209    BD Financial Overview

Table 210    bioMérieux SA Company Overview

Table 211    bioMérieux SA Financial Overview

Table 212    F. Hoffmann-La Roche, Ltd. Company Overview

Table 213    F. Hoffmann-La Roche, Ltd. Financial Overview

Table 214    Hologic, Inc. (Gen-Probe) Company Overview

Table 215    Hologic, Inc. (Gen-Probe) Financial Overview

Table 216    Abbott Company Overview

Table 217    Abbott Financial Overview

Table 218    Quidel Corp. Company Overview

Table 219    Quidel Corp. Financial Overview

Table 220    Siemens Healthineers AG Company Overview

Table 221    Siemens Healthineers AG Financial Overview

Table 222    Bio-Rad Laboratories, Inc. Company Overview

Table 223    Bio-Rad Laboratories, Inc. Financial Overview

Table 224    Danaher Corp. Company Overview

Table 225    Danaher Corp. Financial Overview

Table 226    OraSure Technologies, Inc. Company Overview

Table 227    OraSure Technologies, Inc. Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: The molecular diagnostics segment is expected to hold the highest market share in the Global Infectious Disease In Vitro Diagnostics Market by technology.
Ans: The reagent segment is expected to hold the highest market share in the Global Infectious Disease In Vitro Diagnostics Market by product.
Ans: In 2022, the Global Infectious Disease In Vitro Diagnostics Market size was estimated at USD 35.41 billion in 2022.
Ans: Major factors driving the growth of Global Infectious Disease In Vitro Diagnostics Market include growing geriatric population susceptible to infectious diseases and high demand for PoC testing owing to the pandemic.
Ans: Key players in Global Infectious Disease In Vitro Diagnostics Market include QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corp., and OraSure Technologies, Inc. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1734935477)
}